By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Altor BioScience Corporation 

2810 North Commerce Parkway

Miramar  Florida  33025-3958  U.S.A.
Phone: 954-443-8600 Fax: 954-443-8610


Company News
Despite 'Lowball' Offer, NantCell's Soon-Shiong Snags Altor BioScience In $290 Million Deal 6/27/2017 7:36:35 AM
NantHealth (NH)'s Soon-Shiong Sued for Attempting to Take Over Altor BioScience for a Lowball Price 6/22/2017 6:37:07 AM
Altor BioScience Corporation Announces FDA Fast Track Designation For Lead Candidate ALT-803 In Patients With Non-Muscle Invasive Bladder Cancer 5/2/2017 7:27:10 AM
Altor BioScience Corporation And CMC Biologics Announce Agreement For Manufacture And Validation Of Altor's IL-15 Superagonist Molecule, ALT-803, For Use In Phase III Clinical Trials 4/14/2017 7:47:24 AM
Altor BioScience Corporation And NantKwest Announce Co-Development Agreement To Advance Innovative Natural Killer Cell Combination Immunotherapies For The Treatment Of Cancer 10/4/2016 11:08:52 AM
Altor BioScience Corporation Partners With The NCI To Further Develop Altor’s ALT-803 And ALT-801 Cancer Immunotherapeutics 4/11/2016 8:45:29 AM
Altor BioScience Corporation Announces The Appointment Of Dr. Patrick Soon-Shiong As Chairman Of Its Board Of Directors 4/7/2016 12:00:05 PM
Altor BioScience Corporation Announces National Cancer Institute Phase II SBIR Grant Award And Publication Supporting Ongoing Clinical Trial Of IL-15 Super Agonist ALT-803 In Combination With Anti-CD20 Antibody Therapy For Relapsed / Refractory Non-Hodgkin Lymphoma 10/6/2015 10:58:22 AM
ASCO15: Altor BioScience Corporation Announces Upcoming Data Presentation On Efficacy And Safety Of ALT-801 For Advanced Bladder Cancer At 2015 ASCO Annual Meeting 5/28/2015 11:13:26 AM
Altor BioScience Corporation Announces The Appointment Of Kevin Taylor As Chief Business Officer 1/6/2015 11:49:14 AM